Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Antioxidant/oxidant status and cardiac function in bradykinin B(1)- and B(2)-receptor null mice

S. Delemasure, N. Blaes, C. Richard, R. Couture, M. Bader, P. Dutartre, JP. Girolami, JL. Connat, L. Rochette

. 2013 ; 62 (5) : 511-517.

Language English Country Czech Republic

Document type Journal Article, Research Support, Non-U.S. Gov't

Persistent link   https://www.medvik.cz/link/bmc14066029

Kinin-vasoactive peptides activate two G-protein-coupled receptors (R), B(1)R (inducible) and B(2)R (constitutive). Their complex role in cardiovascular diseases could be related to differential actions on oxidative stress. This study investigated impacts of B(1)R or B(2)R gene deletion in mice on the cardiac function and plasma antioxidant and oxidant status. Echocardiography-Doppler was performed in B(1)R (B(1)R(-/-)) and B(2)R (B(2)R(-/-)) deficient and wild type (WT) adult male mice. No functional alteration was observed in B(2)R(-/-) hearts. B(1)R(-/-) mice had significantly lowered fractional shortening and increased isovolumetric contraction time. The diastolic E and A waves velocity ratio was similar in all mice groups. Thus B(1)R(-/-) mice provide a model of moderate systolic dysfunction, whereas B(2)R(-/-) mice displayed a normal cardiac phenotype. Plasma antioxidant capacity (ORAC) was significantly decreased in both B(1)R(-/-) and B(2)R(-/-) mice whereas the vitamin C levels were decreased in B(2)R(-/-) mice only. Plasma ascorbyl free radical was significantly higher in B(1)R(-/-) compared to WT and B(2)R(-/-) mice. Therefore, the oxidative stress index, ascorbyl free radical to vitamin C ratio, was increased in both B(1)R(-/-) and B(2)R(-/-) mice. Hence, B(1)R and B(2)R deficiency are associated with increased oxidative stress, but there is a differential imbalance between free radical production and antioxidant defense. The interrelationship between the differential B(1)R and B(2)R roles in oxidative stress and cardiovascular diseases remain to be investigated.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc14066029
003      
CZ-PrNML
005      
20140731110226.0
007      
ta
008      
140722s2013 xr d f 000 0|eng||
009      
AR
024    7_
$a 10.33549/physiolres.932496 $2 doi
035    __
$a (PubMed)24020815
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xr
100    1_
$a Delemasure, S. $u COHIRO Biotechnology, Faculty of Medicine, Dijon, France
245    10
$a Antioxidant/oxidant status and cardiac function in bradykinin B(1)- and B(2)-receptor null mice / $c S. Delemasure, N. Blaes, C. Richard, R. Couture, M. Bader, P. Dutartre, JP. Girolami, JL. Connat, L. Rochette
520    9_
$a Kinin-vasoactive peptides activate two G-protein-coupled receptors (R), B(1)R (inducible) and B(2)R (constitutive). Their complex role in cardiovascular diseases could be related to differential actions on oxidative stress. This study investigated impacts of B(1)R or B(2)R gene deletion in mice on the cardiac function and plasma antioxidant and oxidant status. Echocardiography-Doppler was performed in B(1)R (B(1)R(-/-)) and B(2)R (B(2)R(-/-)) deficient and wild type (WT) adult male mice. No functional alteration was observed in B(2)R(-/-) hearts. B(1)R(-/-) mice had significantly lowered fractional shortening and increased isovolumetric contraction time. The diastolic E and A waves velocity ratio was similar in all mice groups. Thus B(1)R(-/-) mice provide a model of moderate systolic dysfunction, whereas B(2)R(-/-) mice displayed a normal cardiac phenotype. Plasma antioxidant capacity (ORAC) was significantly decreased in both B(1)R(-/-) and B(2)R(-/-) mice whereas the vitamin C levels were decreased in B(2)R(-/-) mice only. Plasma ascorbyl free radical was significantly higher in B(1)R(-/-) compared to WT and B(2)R(-/-) mice. Therefore, the oxidative stress index, ascorbyl free radical to vitamin C ratio, was increased in both B(1)R(-/-) and B(2)R(-/-) mice. Hence, B(1)R and B(2)R deficiency are associated with increased oxidative stress, but there is a differential imbalance between free radical production and antioxidant defense. The interrelationship between the differential B(1)R and B(2)R roles in oxidative stress and cardiovascular diseases remain to be investigated.
650    _2
$a zvířata $7 D000818
650    _2
$a antioxidancia $x metabolismus $7 D000975
650    _2
$a biologické markery $x krev $7 D015415
650    _2
$a kyselina dehydroaskorbová $x analogy a deriváty $x krev $7 D003683
650    _2
$a pulzní dopplerovská echokardiografie $7 D018619
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a myši $7 D051379
650    _2
$a myši kmene 129 $7 D057507
650    _2
$a myši inbrední C57BL $7 D008810
650    _2
$a myši knockoutované $7 D018345
650    12
$a kontrakce myokardu $7 D009200
650    _2
$a myokard $x metabolismus $7 D009206
650    12
$a oxidační stres $7 D018384
650    _2
$a receptor bradykininu B1 $x nedostatek $x genetika $7 D043783
650    _2
$a receptor bradykininu B2 $x nedostatek $x genetika $7 D043782
650    _2
$a dysfunkce levé srdeční komory $x krev $x genetika $x metabolismus $x patofyziologie $7 D018487
650    12
$a funkce levé komory srdeční $7 D016277
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Blaes, N. $u Institute of Metabolic and Cardiovascular Diseases (I2MC), INSERM, U1048, Université Paul Sabatier, Toulouse, France
700    1_
$a Richard, C. $u Laboratory of Cardio-Metabolic Pathophysiology and Pharmacology (LPPCM), INSERM, U866, Université de Bourgogne, Dijon, France; Laboratory of Cardio-Metabolic Pathophysiology and Pharmacology (LPPCM), INSERM, U866, Université de Bourgogne, Dijon, France
700    1_
$a Couture, R. $u Department of Physiology, Faculty of Medicine, Université de Montréal, Montréal, Qc, Canada
700    1_
$a Bader, M. $u Max-Delbrück-Center for Molecular Medicine, Berlin, Germany
700    1_
$a Dutartre, P. $u COHIRO Biotechnology, Faculty of Medicine, Dijon, France; Laboratory of Cardio-Metabolic Pathophysiology and Pharmacology (LPPCM), INSERM, U866, Université de Bourgogne, Dijon, France
700    1_
$a Girolami, J.-P. $u Institute of Metabolic and Cardiovascular Diseases (I2MC), INSERM, U1048, Université Paul Sabatier, Toulouse, France
700    1_
$a Connat, J.-L. $u COHIRO Biotechnology, Faculty of Medicine, Dijon, France; Laboratory of Cardio-Metabolic Pathophysiology and Pharmacology (LPPCM), INSERM, U866, Université de Bourgogne, Dijon, France
700    1_
$a Rochette, L. $u COHIRO Biotechnology, Faculty of Medicine, Dijon, France; Laboratory of Cardio-Metabolic Pathophysiology and Pharmacology (LPPCM), INSERM, U866, Université de Bourgogne, Dijon, France
773    0_
$w MED00003824 $t Physiological research $x 1802-9973 $g Roč. 62, č. 5 (2013), s. 511-517
856    41
$u http://www.biomed.cas.cz/physiolres/archive.htm $y domovská stránka časopisu - plný text volně přístupný
910    __
$a ABA008 $b A 4120 $c 266 $y 4 $z 0
990    __
$a 20140722 $b ABA008
991    __
$a 20140730074817 $b ABA008
999    __
$a ok $b bmc $g 1034313 $s 864805
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2013 $b 62 $c 5 $d 511-517 $i 1802-9973 $m Physiological research $n Physiol. Res. (Print) $x MED00003824
LZP    __
$b NLK118 $a Pubmed-20140722
Back

Find record

Citation metrics

Archiving options